Bondi JV - Search Results

1

Formulation design of acidic fibroblast growth factor.

Tsai PK, Volkin DB, Dabora JM, Thompson KC, Bruner MW, Gress JO, Matuszewska B, Keogan M, Bondi JV, Middaugh CR. Tsai PK, et al. Among authors: bondi jv. Pharm Res. 1993 May;10(5):649-59. doi: 10.1023/a:1018939228201. Pharm Res. 1993. PMID: 7686672

2

Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model.

Matuszewska B, Keogan M, Fisher DM, Soper KA, Hoe CM, Huber AC, Bondi JV. Matuszewska B, et al. Among authors: bondi jv. Pharm Res. 1994 Jan;11(1):65-71. doi: 10.1023/a:1018993610801. Pharm Res. 1994. PMID: 7511240

3

Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.

Rupniak NM, Tye SJ, Jennings CA, Loper AE, Bondi JV, Hichens M, Hand E, Iversen SD, Stahl SM. Rupniak NM, et al. Among authors: bondi jv. Neurology. 1989 Mar;39(3):329-35. doi: 10.1212/wnl.39.3.329. Neurology. 1989. PMID: 2784549

4

Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.

Rupniak NM, Tye SJ, Jennings CA, Loper AE, Bondi JV, Hichens M, Iversen SD, Stahl SM. Rupniak NM, et al. Among authors: bondi jv. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):289-90. doi: 10.1136/jnnp.52.2.289. J Neurol Neurosurg Psychiatry. 1989. PMID: 2703851 Free PMC article. No abstract available.

5

The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.

Coleman RJ, Lange KW, Quinn NP, Loper AE, Bondi JV, Hichens M, Stahl SM, Marsden CD. Coleman RJ, et al. Among authors: bondi jv. Mov Disord. 1989;4(2):129-38. doi: 10.1002/mds.870040204. Mov Disord. 1989. PMID: 2733705 Free article.

6

Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.

Vlasses PH, Ribeiro LG, Rotmensch HH, Bondi JV, Loper AE, Hichens M, Dunlay MC, Ferguson RK. Vlasses PH, et al. Among authors: bondi jv. J Cardiovasc Pharmacol. 1985 Mar-Apr;7(2):245-50. doi: 10.1097/00005344-198503000-00006. J Cardiovasc Pharmacol. 1985. PMID: 2581075 Clinical Trial.

7

Estradiol distribution and penetration in rat skin after topical application, studied by high resolution autoradiography.

Bidmon HJ, Pitts JD, Solomon HF, Bondi JV, Stumpf WE. Bidmon HJ, et al. Among authors: bondi jv. Histochemistry. 1990;95(1):43-54. doi: 10.1007/BF00737227. Histochemistry. 1990. PMID: 2286532

8

2'-Nor-2'-deoxyguanosine is an effective therapeutic agent for treatment of experimental herpes keratitis.

Davies ME, Bondi JV, Grabowski L, Schofield TL, Field AK. Davies ME, et al. Among authors: bondi jv. Antiviral Res. 1987 Feb;7(2):119-25. doi: 10.1016/0166-3542(87)90027-1. Antiviral Res. 1987. PMID: 3495237

9

Dissolution rate studies of compression-molded units made from hydroxypropyl cellulose films.

Grabowski LA, Bondi JV, Harwood RJ. Grabowski LA, et al. Among authors: bondi jv. J Pharm Sci. 1985 May;74(5):540-4. doi: 10.1002/jps.2600740509. J Pharm Sci. 1985. PMID: 4020630

10

Efficacy of 2'-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in mice.

Davies ME, Bondi JV, Field AK. Davies ME, et al. Among authors: bondi jv. Antimicrob Agents Chemother. 1984 Feb;25(2):238-41. doi: 10.1128/AAC.25.2.238. Antimicrob Agents Chemother. 1984. PMID: 6608919 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page